Expert session: Guillain – Barré Syndrome
Guillain Barré syndrome (GBS) is the prototypic syndrome and the foremost cause of neuromuscular paralysis worldwide with a global incidence of ~1.5/105. Onset can be rapid, leading to total paralysis within 48hrs and the therapeutic window for GBS is short. The patients left severely disabled or dead represent a major social and economic burden, as well as suffering individually from the effects of this devastating and life-changing disease. In this presentation one patient affected by GBS (Patricia Blomkwist-Markens) will engage in an expert discussion with a GBS researcher (Hugh Willison) in an effort to identify the salient features as they are seen by patients and match these with the research efforts taking place in this area. The presentation will discuss antecedent events, clinical evolution, treatment strategies, outcome and residual disability. The audience will be able to ask questions throughout the presentation, and in a final Q&A session.